Fred Hutchinson HIV Vaccine Study Survey

Dates: 2010-2011

Geographic Scope: Nationwide

Client(s): Fred Hutchinson Cancer Research Center, National Institutes of Health (NIH)

Services: Health Communication, Applied Research & Evaluation

Technical Expertise: Health Disparities, HIV & Infectious Diseases, Lesbian, Gay, Bisexual, and Transgender (LGBT) Health


The Fred Hutchinson Cancer Research Center (FHCRC) contracted with JSI to implement a survey identifying barriers and ways to facilitate participation in HIV vaccine research among gay and bisexual men. The survey was implemented in six cities: Boston, New York, Chicago, Denver, Houston and Los Angeles and included a combination of online and face-to-face survey respondents.

JSI utilized a combination of online, print and transport advertising to recruit men to complete online surveys as well as in-person surveys. Over 10,000 men who have sex with men were screened to identify and complete 1800 surveys among eligibles. JSI conducted focus groups with gay and bisexual men in each of the six cities to complement the survey's quantitative findings with a qualitative component.

These data were dedicated to help FHCRC researchers develop a strategic plan to support enrollment in an HIV vaccine trial (HVTN 505 study) sponsored by the HIV Vaccine Trials Network. In April 2013, an independent data and safety monitoring board found that the vaccine did not prevent HIV infection nor reduce viral load among vaccine recipients who became infected with HIV, so the trial has been stopped.